Skip to main content

How Much Regulation is Desirable in Industry?

  • Chapter
  • 81 Accesses

Abstract

Never having been an employee of the pharmaceutical industry, my approach is that of an outsider looking in, with all the advantages and disadvantages which that description entails. I shall try to avoid seeming just a voyeur or a eunuch giving lessons in the art of love and shall focus on what measures and approaches might maximise the public good as well as the ability of the drug industry to contribute to improvements in public health. Industry will continue to be our major source of important new medicines, so that its health and vigour are vital to the introduction of the new drugs so desperately needed to treat the sick.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

Download references

Authors

Editor information

Hugh L’etang

Copyright information

© 1983 The Royal Society of Medicine

About this chapter

Cite this chapter

Lasagna, L. (1983). How Much Regulation is Desirable in Industry?. In: L’etang, H. (eds) Regulation and Restraint in Contemporary Medicine in the UK and USA. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06501-1_17

Download citation

Publish with us

Policies and ethics